USSTOCK.TODAY
Weekend. Closed
Log in Sign up
ETF Profiles

What Is the DRKY ETF? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs

Updated August 18, 2026 · First published August 18, 2026

The Vistashares Target 15 Drugmacro Distribution ETF (DRKY) is an actively managed product that combines equity exposure based on publicly disclosed holdings with an options overlay. When evaluating its dividend-like cash flow, investors should review the source of distributions, the concentration of holdings, and the outlook for total return together.

Briefs · earnings · signals, first Subscribe
🏷️

What Is the Vistashares Target 15 Drugmacro Distribution ETF?

The DRKY ETF is an actively managed product that seeks cash flow by combining an equity portfolio based on publicly disclosed Duquesne Family Office holdings with an options strategy. Because the basis for index inclusion is public information, it may differ from the actual positions currently held.

It suits investors who want to maintain equity exposure, understand the structure and potential variability of option-based cash flow, and review total return and changes in asset value alongside distributions.

It is an ETF managed by Vistashares using an active management approach.

💰

How Does the Vistashares Target 15 Drugmacro Distribution ETF Invest?

ItemDetails
Tracked indexVita Vistashares Drugmacro Select Index
Management styleActive equity and options management
Rebalancing frequencyAdjusted at the manager's discretion
Distribution frequencyDistribution history exists (irregular schedule, so a fixed frequency should not be assumed)
Expense ratio0.95%
ManagerVistashares

This product seeks income by managing option positions on top of an equity portfolio built from publicly disclosed holdings. Option premiums can be a source of cash flow, but they may limit participation in rising markets and expose the fund to derivatives price swings. Official holdings can change at any time, so the actual composition should be checked separately in the manager's materials.

  • Uses publicly disclosed holdings information
  • Seeks income through options
📐

Vistashares Target 15 Drugmacro Distribution ETF Size and Costs (AUM and Management Fee)

Assets under management (AUM) are $22.4M, and the expense ratio is 0.95% per year.

As a newly launched product, trading volume and bid-ask spreads may vary with market participation. For long-term holders, it is worth checking how fees and the options strategy affect actual total return.

📈

Vistashares Target 15 Drugmacro Distribution ETF Performance and Trends

1-Year Price Performance
Dividend & Yield
Dividend Yield 15.27%
Annual Dividend (TTM) $3.13
1Y Return -0.6%
Next Ex-Dividend Date 10/26/2026
52-Week Price Range
$21
Low $18 High $23
vs. low +12.59% vs. high -9.76%

The fund has a short listing history, so the available data is limited for drawing general conclusions about long-term performance. The concentration of the equity portfolio, the option premium environment, macro variables, and the volatility of individual holdings can all influence net asset value and market price movements.

Demand for income-oriented options strategies can shift depending on expectations for cash flow and perceptions of share price volatility. Distributions may include a return of capital in addition to option income, so performance should be judged by changes in net asset value and total return rather than by cash payouts alone.

⚔️

Vistashares Target 15 Drugmacro Distribution ETF Pros and Cons

The fund is characterized by its use of publicly disclosed holdings and option-based income, but investors should also consider information lags and the variability of distribution sources.

💪 Key Strengths

Public information-based approach
Publicly disclosed holdings help investors understand the starting point of the portfolio's construction.
Options income strategy
It combines an equity portfolio with options management to pursue cash flow.
Partial participation in rallies
Equity exposure leaves room to participate in the upside of the underlying portfolio.

⚠️ Points to Watch

Delay in public information
Publicly disclosed holdings may differ from the latest positions of the actual investor.
Limited option upside
Option-selling strategies earn premiums but can reduce participation when share prices surge.
Variable distribution sources
Distributions are not guaranteed, and any return of capital can affect net asset value.
🔄

Alternative ETFs and Related Products to the Vistashares Target 15 Drugmacro Distribution ETF

In the comparison table, the EZU ETF focuses on eurozone equities, the VPL ETF on Pacific region equities, the AIA ETF on large-cap Asian stocks, the ILF ETF on Latin American equities, and the BDYN ETF on active equity strategies. These products differ in region or management approach, so rather than direct substitutes for the DRKY ETF, they are better viewed as reference points for comparing equity exposure and management approaches. Because the candidate information provided is limited, no additional ticker-based alternatives are presented.

Peer Comparison ETFs
TickerNamePriceChangeAUMTotal Expense RatioDividend Yield1Y
EZUEZUiShares MSCI EMU ETF$65.16-1.6%$9.2B0.50%2.83%+4.4%
VPLVPLVanguard FTSE Pacific ETF$108.71-2.3%$8.6B0.07%2.23%+19.0%
AIAAIAiShares Asia 50 ETF$126.95-3.5%$4.7B0.50%0.99%+29.1%
ILFILFiShares Latin America 40 ETF$32.13-1.7%$3.4B0.47%3.03%+10.1%
BDYNBDYNiShares Dynamic Equity Active ETF$27.10-2.3%$3.2B0.39%0.32%+6.8%
Top Holdings
TickerNameWeightPriceChangeMarket CapP/EDividend Yield
USLMUSLMUnited States Lime & Minerals Inc0.57%$111.61-2.0%$3.2B23.90.22%
UAMYUAMYUnited States Antimony Corp0.22%$2.98-5.7%$446.0M--
AMZNAmazon.com Inc0.20%$240.35-1.4%$2.59T19.4-
MUMicron Technology Inc0.12%$884.74-5.3%$1.00T11.90.08%
FAFFAFFirst American Financial Corp0.11%$63.82+0.2%$6.5B9.03.64%
BABAAlibaba Group Holding Ltd ADR0.10%$98.04-1.5%$243.9B23.11.14%
TSMTaiwan Semiconductor Manufacturing ADR0.08%$406.13-6.0%$2.11T26.11.01%
GOOGLAlphabet Inc0.07%$279.84-1.4%$3.41T14.60.31%
✅

Vistashares Target 15 Drugmacro Distribution ETF Investor Checkpoints

The DRKY ETF structure uses equity exposure and options management together, so investors should not judge it by distributions alone. They should also check how the concentration of the underlying portfolio and the options strategy affect upside participation and downside risk.

CheckpointWhat to CheckCurrent Status
💵 Fees and costsCheck how costs affect total return over a long holding periodCost structure needs review
💧 Trading conditionsReview bid-ask spreads and trading volume before placing ordersTrading conditions need review
📊 PortfolioCheck the time lag between public information and actual holdingsBased on public information
💱 Distribution sourceCheck for option income and the possibility of return of capitalDistribution source needs review

The DRKY ETF carries the risks of a lag in publicly disclosed holdings, a relatively concentrated portfolio, and price fluctuations in option contracts. Selling options can provide premiums but may restrict participation in share price gains, and there is no guarantee that distributions will continue.

The DRKY ETF is a product worth examining for those who want to understand equity exposure based on publicly disclosed holdings together with option-based cash flow. However, investors need to review the composition of distributions, the concentration of holdings, and changes in actual total return and net asset value together.

Briefs · earnings · signals, first Subscribe

Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.

This article reflects information as of August 18, 2026.

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →